Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Chen (Tainan, Taiwan). Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients. 4957

Member's Comments

No comment yet.

Related content which might interest you: GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Distribution of COPD patients in the GOLD assessment framework by exacerbations Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Mortality and readmissions in patients with severe COPD. Validation of the CODEX index Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Prediction models for exacerbations in patients with COPD Source: Eur Respir Rev 2017; 26: 160061 Year: 2017 Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death? Source: Breathe, 17 (4) 210046; 10.1183/20734735.0046-2021 Year: 2021 Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 COPD comorbidities and risk assessment according to GOLD 2011 revision Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Implementation of the GOLD 2017 disease classification in a real-life COPD cohort Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data Source: ERJ Open Res, 6 (4) 00253-2020; 10.1183/23120541.00253-2020 Year: 2020 10-year cumulative incidence of COPD in a symptomatic cohort using BTS and GOLD spirometric criteria Source: Eur Respir J 2003; 22: Suppl. 45, 214s Year: 2003 Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Validation of non-spirometric predictors of COPD to the GOLD stage classification Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002 Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging systems: a pooled analysis of individual patient data Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014 LATE-BREAKING ABSTRACT: Validation of the DECAF score to predict hospital mortality in exacerbations of COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015